High-performance liquid chromatographic analysis of angiotensin II receptor antagonist valsartan using a liquid extraction method

J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Jan 25;766(2):345-9. doi: 10.1016/s0378-4347(01)00507-2.

Abstract

Purpose: To develop an easy assay for the quantitation of the angiotensin II receptor antagonist valsartan in human plasma using a liquid extraction procedure.

Method: The method involves acid extraction from 1 ml human plasma with methyl-tert.-butyl ether followed by back-extraction into a basic medium. An isocratic HPLC equipped with reverse phase column and a fluorescence detector was used at room temperature.

Results: The response to 10-2000 ng/ml valsartan was linear. In plasma of three human subjects given 160 mg valsartan orally, concentrations of 25-1540 ng/ml were observed.

Conclusion: This convenient method is suitable for pharmacokinetic studies of valsartan.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiotensin II / metabolism*
  • Angiotensin Receptor Antagonists*
  • Antihypertensive Agents / blood*
  • Antihypertensive Agents / pharmacokinetics
  • Chromatography, High Pressure Liquid / methods*
  • Humans
  • Receptors, Angiotensin / metabolism
  • Reference Standards
  • Reproducibility of Results
  • Spectrometry, Fluorescence
  • Tetrazoles / blood*
  • Tetrazoles / pharmacokinetics
  • Valine / analogs & derivatives
  • Valine / blood*
  • Valine / pharmacokinetics
  • Valsartan

Substances

  • Angiotensin Receptor Antagonists
  • Antihypertensive Agents
  • Receptors, Angiotensin
  • Tetrazoles
  • Angiotensin II
  • Valsartan
  • Valine